Drug Delivery from Hyaluronic Acid–BDDE Injectable Hydrogels for Antibacterial and Anti-Inflammatory Applications

2022-04-20T08:03:13+01:00

Drug Delivery from Hyaluronic Acid–BDDE Injectable Hydrogels for Antibacterial and Anti-Inflammatory Applications Injectable hyaluronic acid (HA) biomaterials are currently applied in numerous biomedical areas and due to their widespread use, bacterial infections and painful inflammation are associated with post-injection health complications. In this article, i+Med successfully crosslinks HA hydrogels with [...]

Drug Delivery from Hyaluronic Acid–BDDE Injectable Hydrogels for Antibacterial and Anti-Inflammatory Applications2022-04-20T08:03:13+01:00

i+Med invests 20 million euros and promotes the world’s first Biomedical Institute for Intelligent Nanohydrogels [Press release]

2022-05-18T09:57:03+01:00

i+Med invests 20 million euros and promotes the world's first Biomedical Institute for Intelligent Nanohydrogels The investment will initially generate 60 new highly qualified jobs. The Institute will also be its new headquarters and will be located in the Alava Technologic Park. The project consolidates i+Med in the field [...]

i+Med invests 20 million euros and promotes the world’s first Biomedical Institute for Intelligent Nanohydrogels [Press release]2022-05-18T09:57:03+01:00

Spontaneous gelation of hyaluronic acid modified with catechol and chitosan

2022-03-30T16:47:42+01:00

Spontaneous gelation of hyaluronic acid modified with catechol and chitosan As experts in nanohydrogels for the controlled release of drugs and active substances, studying gelation behaviour is vital for our products and technologies. In this article in collaboration with the LABQUIMAC team from the UPV EHU we successfully analysed the [...]

Spontaneous gelation of hyaluronic acid modified with catechol and chitosan2022-03-30T16:47:42+01:00

i+Med introduces BuddyDrops®, the only sustained-release ectoin eye drops for pets

2022-02-25T12:18:55+01:00

i+Med introduces BuddyDrops®, the only sustained-release ectoin eye drops for pets From @i+Med we present BuddyDrops®, a novel long-lasting moisturising and lubricating eye drop that helps to maintain moisture and eye hygiene in pets. BuddyDrops® are the only drops on the market with a combination of ectoine, hyaluronic acid and [...]

i+Med introduces BuddyDrops®, the only sustained-release ectoin eye drops for pets2022-02-25T12:18:55+01:00

Wound healing and antibacterial chitosan-genipin hydrogels with controlled drug delivery for synergistic anti-inflammatory activity

2022-02-08T11:25:46+01:00

Wound healing and antibacterial chitosan-genipin hydrogels with controlled drug delivery for synergistic anti-inflammatory activity An ideal material for wound healing must be biocompatible, biodegradable, easily applicable, highly stable and able to protect the wound from infection. One of these biomaterials, which are attracting huge attention in recent years, are smart [...]

Wound healing and antibacterial chitosan-genipin hydrogels with controlled drug delivery for synergistic anti-inflammatory activity2022-02-08T11:25:46+01:00

Scientific review on bioinks and bioprinting technologies as cellular scaffolds for bone tissues and the use of hidroxiapatite

2022-01-11T12:50:52+01:00

Scientific analysis on bioinks and bioprinting technologies for the coating as cellular scaffolds for bone tissues and the use of hidroxiapatite i+Med reviews the different types of bioprinting and coating technologies and the essential parameters operating the applicability of bioinks with an emphasis on hydroxyapatite as the active [...]

Scientific review on bioinks and bioprinting technologies as cellular scaffolds for bone tissues and the use of hidroxiapatite2022-01-11T12:50:52+01:00

imasmed footer

i+Med es un laboratorio dedicado a la investigación, desarrollo y fabricación de nuevos productos en el campo de la ingeniería biomédica. Nos especializamos en la generación de sistemas inteligentes personalizados de liberación controlada adaptados a las necesidades de cada cliente, siempre bajo un estricto control (ISO 13485:2016) del proceso de fabricación y una exigente política de calidad.
SPECIFIC CONTACTS
Go to Top